氨磺必利和利培酮治疗首发精神分裂症疗效和安全性对析,本文是一篇关于利培酮论文范文，可作为相关选题参考,和写作参考文献。
利培酮论文参考文献：
DOI：10.16662/j.cnki.1674-0742.2017.23.138
[摘 要] 目的 研究氨磺必利和利培酮治疗首发精神分裂症患者的临床效果安全性.方法 方便选取该院2015年8月—2016年12月期间所收治的64例首发精神分裂症患者进行研究,对患者进行随机分组,研究组和对照组,每组32例,对照组应用利培酮治疗,研究组应用氨磺必利治疗,对 析两组患者的治疗总有效率和不良反应发生情况（TESS评分）,观察两组患者的阴性和阳性综合征量表评分和CDSS评分.结果 研究组治疗总有效率为84.38%,对照组治疗总有效率为81.25%,两组差异无统计学意义（P>0.05）.治疗后研究组患者PANSS阴性减分（8.24±5.15）分、CDSS评分（6.41±1.52）分和对照组[（5.62±4.13）分、（5.23±2.40）分]比較差异有统计学意义,且研究组患者的不良反应发生率（25.00%）显著低于对照组（53.13%）,两组差异有统计学意义（P<0.05）.结论 在首发精神分裂症患者应用氨磺必利治疗的效果与利培酮相比,差异无统计学意义,但是若患者的临床症状属阴性症状,那么可以应用氨磺必利进行治疗,效果更为明显,且不良反应少,具有较高的安全性,值得推广应用.
[关键词] 氨磺必利；利培酮；首发精神分裂症；安全性
[中图分类号] R749 [文献标识码] A [文章编号] 1674-0742（2017）08（b）-0138-03
Comparative Analysis of the Efficacy and Safety of Amisulpride and Risperidone in the Treatment of First-episode Schizophrenia
WANG Yan-hong
Department of Psychiatry, Heze No.3 People’s Hospital, Heze, Shandong Province, 274000 China
[Abstracts] Objective Objective This paper tries to study the clinical efficacy of amisulpride and risperidone in the treatment of first-episode schizophrenic patients. Methods 64 cases treated in this hospital during August 2015 to December 2016 were conveniently selected and randomly divided into the study group and the control group, with 32 cases in each group, the control group was treated with risperidone treatment, the study group was treated with amisulpride, the total effective rate of treatment and adverse reactions （TESS score） of the two groups were observed, and the negative and positive syndrome scale and CDSS score were observed. Results The total effective rate was 84.38% in the study group, the total effective rate in the control group was 81.25%, there was no significant difference between the two groups（P>0.05）； PANSS negative score of the study group after treatment was （8.24±5.15）points, CDSS subtraction was （6.41±1.52）points and that of the control group was（5.62±4.13）points, （5.23±2.40）points, the difference was significantly different, and the incidence of adverse reactions in the study group was 25.00%, significantly lower than in the control group of 53.13%, and the difference was statistically significant（P<0.05）. Conclusion There is no significant difference in the efficacy of amisulpride treatment in patients with first-episode schizophrenia compared with risperidone, but if the clinical symptoms of patients are negative, then the effect of amisulpride is more obvious, with fewer adverse reactions and high security, it is worth promotion and application.
结论：适合利培酮论文写作的大学硕士及相关本科毕业论文，相关利培酮口崩片开题报告范文和学术职称论文参考文献下载。
义为利中国思想之根本精神
世人不少以为中国文化是道德的而非科学的，甚至是直观的而非合理的。如是许多人亦以为我们虽拙于戡天科学，但长于“君子之道”云。并以此为中西文化之先天。
利培酮片对首发精神分裂症安全用药管理
[摘要] 目的 探讨利培酮片对首发精神分裂症的安全用药管理。方法 选取入住该院的首发精神分裂症患者78例，随机分为对照组和研究组，对照组采用利培。
吴培华韧之精神书写传奇职业生涯
从江南的苏州大学出版社到北国的清华大学出版社，“一种职业，两段精彩”，“韧”之精神，贯穿吴培华出版生涯的始终。“我们要造出大群的新的战士，但同。
小剂量氨氯地平联合用药治疗老年高血压疗效和安全性评价
摘要：目的：评价应用小剂量氨氯地平联合用药治疗老年高血压的疗效和安全性。方法：将我科2015年3月～2016年1月门诊收治的老年高血压患者随机分。